Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00304408 · ClinicalTrials.gov registry record
Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody
A clinical trial, sponsored by Michael E. DeBakey VA Medical Center.
- Completed
- Registry status
- 10
- Enrollment target
NCT00304408: Completed study, sponsored by Michael E. DeBakey VA Medical Center.
NCT00304408 is a clinical trial that has completed, run by Michael E. DeBakey VA Medical Center. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00304408 has completed, sponsored by Michael E. DeBakey VA Medical Center.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is three fold: 1)To collect serum from patients with documented Clostridium difficile infection and test for the presence of antibody to C. difficile toxin at the start and at the end of therapy, and again if a relapse or recurrence occurs. 2)To collect stool samples for test of C. difficile toxin at similar time intervals. 3)To assay random serum samples from the VA lab in order to determine the rate of antibody to C. difficile toxin in our patient population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-01 |
What the finished NCT00304408 record still lists
NCT00304408 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00304408 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00304408 about?
NCT00304408 is a clinical study titled "Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody". The purpose of this study is three fold: 1)To collect serum from patients with documented Clostridium difficile infection and test for the presence of antibody to C. difficile toxin at the start and at the end of therapy, and again if a relapse or recurrence occurs. 2)To collect stool samples for te...
What is the current status of trial NCT00304408?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2005-01. Estimated completion is 2008-01.
Who is sponsoring clinical trial NCT00304408?
This trial is sponsored by Michael E. DeBakey VA Medical Center, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia